caa a22 4500 467922225 CHVBK 20180406152920.0 cr unu---uuuuu 170328e20060501xx s 000 0 ger 10.1007/s10309-006-0192-2 doi (NATIONALLICENCE)springer-10.1007/s10309-006-0192-2 Schulze-Bonhage Andreas Leiter des Epilepsiezentrums am Universitätsklinikum Freiburg, Breisacher Str. 64, 79106, Freiburg aut SUDEP bei epilepsiechirurgisch behandelten Patienten [Elektronische Daten] [Andreas Schulze-Bonhage] SUDEP in patients treated by epilepsy surgery Patients with pharmacoresistant focal epilepsy have a considerably increased risk for the unexpected occurrence of death (SUDEP). It is thus particularly interesting to determine if treatment by epilepsy surgery can decrease this risk. This review presents data on the SUDEP risk in pharmacorefractory focal epilepsy with pharmacologic or surgical treatment. Study results are critically discussed. The establishment of a prospective multicentre registry of SUDEP and relevant risk factors is advocated. Steinkopff-Verlag, 2006 SUDEP nationallicence mortality nationallicence focal epilepsy nationallicence epilepsy surgery nationallicence SUDEP nationallicence Mortalität nationallicence fokale Epilepsie nationallicence Epilepsiechirurgie nationallicence Zeitschrift für Epileptologie Steinkopff-Verlag 19/2(2006-05-01), 77-83 1617-6782 19:2<77 2006 19 10309 https://doi.org/10.1007/s10309-006-0192-2 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10309-006-0192-2 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Schulze-Bonhage Andreas Leiter des Epilepsiezentrums am Universitätsklinikum Freiburg, Breisacher Str. 64, 79106, Freiburg aut NATIONALLICENCE 773 0- Zeitschrift für Epileptologie Steinkopff-Verlag 19/2(2006-05-01), 77-83 1617-6782 19:2<77 2006 19 10309 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer